Condition
Biphozyl
Total Trials
1
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
4 treatments under study, led by Cvvh With Biphozyl In The Second 48h After Randomization After Previous 48h With Phoxilium
Related Conditions
Often studied with 9 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Phase 2 (1)
Trial Status
Completed1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (1)
Research Network
Common Treatments
- Cvvh With Biphozyl In The Second 48h After Randomization After Previous 48h With Phoxilium1
- Cvvh With Biphozyl In The First 48h After Randomization1
- Cvvh With Phoxilium In The Second 48h After Randomization After Previous 48h With Biphozyl1
- Cvvh With Phoxilium In The First 48h After Randomization1
Active Sponsors
- Medical University Innsbruck1
Top Investigators
Medical University Innsbruck
Related Conditions
- Critically Ill1
- Regional Citrate Anticoagulation1
- Acute Kidney Injury1
- Continuous Venovenous Hemofiltration1
- Phoxilium1